ClinicalTrials.Veeva

Menu

Cognitive Remediation of Schizophrenia in a Community Mental Health Setting (SECT)

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status

Completed

Conditions

Experimental Condition TCT
Controlled Condition CG

Treatments

Other: (TCT) plus evidence-based SE
Other: (CG) plus evidence-based SE

Study type

Interventional

Funder types

Other

Identifiers

NCT01988714
R01MH068725 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to investigate the usefulness of neuroscience-guided cognitive training combined with community-based supported employment for people with schizophrenia. The investigators will examine the effectiveness of moving our study of neuroplasticity-based restorative targeted cognitive training out of the laboratory and into the community setting; and the investigators will also investigate its utility in enhancing functional outcome in chronically mentally ill adults who are participating in supported employment.

Full description

Neurocognitive functioning will be assessed at baseline (study entry), after cognitive training (6 months), and at 12 month follow-up, using the MATRICS Consensus Cognitive Battery (MCCB). The investigators will assess the following six constructs identified by MATRICS as separable, fundamental dimensions of cognitive impairment in schizophrenia, with a likely sensitivity to intervention [26]: 1) Speed of Processing, 2) Attention/Vigilance, 3) Working Memory, 4) Verbal Learning and Memory, 5) Visual Learning and Memory, and 6) Reasoning and Problem Solving (executive functioning). The investigators will also administer the delayed memory trials of HVLT and BVMT, Trails B, and D-KEFS Color-Word Interference Test [27], and will make one modification to the MCCB in utilizing BACS Tower of London [28] in place of NAB Mazes.

Enrollment

112 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosis of schizophrenia or schizoaffective disorder(DSM-IV criteria)
  • between the ages of 18-65
  • English as primary language (learned before age 12)
  • no major medical or neurological disorder that precludes participation in the study

Exclusion criteria

  • We will not exclude subjects with substance abuse or dependence as we wish to investigate the real-world effectiveness of this cognitive remediation approach when combined with SE. As per the clinical policy at Community Services, however, patients will not be permitted to attend the SE program or to participate in the study if they are acutely intoxicated. Subjects who miss 5 consecutive days of participation due to intoxication will be dropped and a replacement subject will be recruited.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

112 participants in 2 patient groups, including a placebo group

(TCT) plus evidence-based SE
Experimental group
Description:
(TCT) plus evidence-based SE
Treatment:
Other: (CG) plus evidence-based SE
(CG) plus evidence-based SE
Placebo Comparator group
Description:
(CG) plus evidence-based SE
Treatment:
Other: (TCT) plus evidence-based SE

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems